Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gliosarcoma: A Reappraisal of Neuroradiological, Surgical, Morphological, and Radiotherapeutic Characteristics of a Cohort From South Italy Single-Center.

Analytical cellular pathology (Amsterdam)·2026

Same author

Epigenetic crosstalk between uric acid and vascular health: a role for extracellular vesicles.

Clinical epigenetics·2025

Same author

Beyond Anthropometry: The Clinical Role of Epigenetics in Prenatal Programming of Obesity.

American journal of preventive medicine·2025

Same author

A pilot study on DNA methylation changes for non-invasive molecular diagnostics in heart failure.

ESC heart failure·2025

Same author

Design and Development of a Device (Sifilotto<sup>®</sup>) for Tumour Tracking in Cervical Cancer Patients Undergoing Robotic Arm LINAC Stereotactic Body Radiation Therapy Boost: Background to the STARBACS Study.

Current oncology (Toronto, Ont.)·2025

Same author

Mediator complex: update of key insights into transcriptional regulation of ancestral framework and its role in cardiovascular diseases.

European journal of medical research·2025

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Quantitative Analysis of Chromatin Proteomes in Disease

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

Proteomics and cardiovascular disease: an update.

Maria Luisa Balestrieri¹, Alfonso Giovane, Francesco Paolo Mancini

¹Department of Biochemistry and Biophysics, Complesso S. Andrea delle Dame, 1st School of Medicine, II University of Naples, Naples, Italy.

Current Medicinal Chemistry

|March 14, 2008

Summary

Proteomics offers new ways to detect cardiovascular disease early and monitor treatments using advanced technology. Combining proteomic biomarkers with other data can improve risk assessment for patients.

More Related Videos

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

Quantitative Analysis of Chromatin Proteomes in Disease

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

Area of Science:

Cardiovascular Biology
Biomarker Discovery
Proteomics

Background:

Proteomics has significantly advanced our understanding of cardiovascular disease (CVD) biology.
It holds substantial promise for developing novel diagnostic and prognostic biomarkers for CVD.
This can lead to early detection strategies and improved monitoring of therapeutic responses.

Purpose of the Study:

To highlight the role of proteomics in cardiovascular disease research.
To discuss the potential of proteomic biomarkers for early detection and therapy monitoring.
To explore the integration of proteomic data with other biological and clinical information for risk assessment.

Main Methods:

Technological advancements in proteomics, including blue native polyacrylamide gel electrophoresis, electrospray ionization, and matrix-assisted laser desorption/ionization (MALDI).
Analysis of MALDI-derived peptides using Time-of-Flight (TOF) analyzers.
Multidimensional protein identification technology (MudPIT) coupled with bioinformatics for large-scale peptide and post-translational modification identification.

Main Results:

Proteomics enables large-scale identification of peptide sequences and post-translational modifications.
Technological progress facilitates comprehensive protein analysis.
Integration of proteomic biomarkers with clinical, metabolic, and genetic data enhances cardiovascular risk profiling.

Conclusions:

Proteomics is a powerful tool for unraveling cardiovascular disease biology.
Proteomic biomarkers are promising for early detection, prognosis, and therapy monitoring in CVD.
Combining proteomic insights with diverse data types offers a comprehensive approach to personalized cardiovascular risk assessment.